Imaging surveillance programs for women at high breast cancer risk in Europe: Are women from ethnic minority groups adequately included? (Review)

Belkić,Karen; Cohen,Miri; Wilczek,Brigitte; Andersson,Sonia; Berman,Anne  H.; Márquez,Marcela; Vukojević,Vladana; Mints,Miriam

doi:10.3892/ijo.2015.3063

Imaging surveillance programs for women at high breast cancer risk in Europe: Are women from ethnic minority groups adequately included? (Review)

Authors:
- Karen Belkić
- Miri Cohen
- Brigitte Wilczek
- Sonia Andersson
- Anne H. Berman
- Marcela Márquez
- Vladana Vukojević
- Miriam Mints
View Affiliations

Affiliations: The Karolinska Institute and Hospital, Departments of Oncology-Pathology, Women's and Children's Health and of Clinical Neuroscience, Stockholm, Sweden, University of Haifa, Faculty of Social Welfare and Health Sciences, Haifa, Israel, Sankt Görans Hospital, Unilabs Department of Mammography, Stockholm, Sweden
Published online on: June 26, 2015 https://doi.org/10.3892/ijo.2015.3063
Pages: 817-839

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Women from ethnic minority groups, including immigrants and refugees are reported to have low breast cancer (BC) screening rates. Active, culturally-sensitive outreach is vital for increasing participation of these women in BC screening programs. Women at high BC risk and who belong to an ethnic minority group are of special concern. Such women could benefit from ongoing trials aimed at optimizing screening strategies for early BC detection among those at increased BC risk. Considering the marked disparities in BC survival in Europe and its enormous and dynamic ethnic diversity, these issues are extremely timely for Europe. We systematically reviewed the literature concerning European surveillance studies that had imaging in the protocol and that targeted women at high BC risk. The aim of the present review was thereby to assess the likelihood that women at high BC risk from minority ethnic groups were adequately included in these surveillance programs. Twenty-seven research groups in Europe reported on their imaging surveillance programs for women at increased BC risk. The benefit of strategies such as inclusion of magnetic resonance imaging and/or more intensive screening was clearly documented for the participating women at increased BC risk. However, none of the reports indicated that sufficient outreach was performed to ensure that women at increased BC risk from minority ethnic groups were adequately included in these surveillance programs. On the basis of this systematic review, we conclude that the specific screening needs of ethnic minority women at increased BC risk have not yet been met in Europe. Active, culturally-sensitive outreach is needed to identify minority women at increased BC risk and to facilitate their inclusion in on-going surveillance programs. It is anticipated that these efforts would be most effective if coordinated with the development of European-wide, population-based approaches to BC screening.

View Figures

View References

1	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI
2	Perry N, Broeders M, de Wolf C, Törnberg S, Holland R and von Karsa L: European guidelines for quality assurance in breast cancer screening and diagnosis Fourth edition - summary document. Ann Oncol. 19:614–622. 2008. View Article : Google Scholar
3	Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW, Coleman MP, Grosclaude P, Martinez C, Bell J, et al; EUROCARE Working Group. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer. 106:416–422. 2003. View Article : Google Scholar : PubMed/NCBI
4	Armstrong K, Moye E, Williams S, Berlin JA and Reynolds EE: Screening mammography in women 40 to 49 years of age: A systematic review for the American College of Physicians. Ann Intern Med. 146:516–526. 2007. View Article : Google Scholar : PubMed/NCBI
5	Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, et al; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 57:75–89. 2007. View Article : Google Scholar : PubMed/NCBI
6	Sabatino SA, Burns RB, Davis RB, Phillips RS, Chen YH and McCarthy EP: Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: Results from a national survey. Cancer. 100:2338–2346. 2004. View Article : Google Scholar : PubMed/NCBI
7	Evans JP, Skrzynia C, Susswein L and Harlan M: Genetics and the young woman with breast cancer. Breast Dis. 23:17–29. 2006.PubMed/NCBI
8	Klauber-DeMore N: Tumor biology of breast cancer in young women. Breast Dis. 23:9–15. 2006.PubMed/NCBI
9	Kurian AW, Hartman AR, Mills MA, Ford JM, Daniel BL and Plevritis SK: Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: An initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect. 8:221–233. 2005. View Article : Google Scholar : PubMed/NCBI
10	Clements A, Henderson BJ, Tyndel S, Evans G, Brain K, Austoker J and Watson E; PIMMS Study Management Group. Diagnosed with breast cancer while on a family history screening programme: An exploratory qualitative study. Eur J Cancer Care (Engl). 17:245–252. 2008. View Article : Google Scholar
11	Bermejo-Pérez MJ, Márquez-Calderón S and Llanos-Méndez A: Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: A systematic review. Br J Radiol. 81:172–179. 2008. View Article : Google Scholar : PubMed/NCBI
12	Willey SC and Cocilovo C: Screening and follow-up of the patient at high risk for breast cancer. Obstet Gynecol. 110:1404–1416. 2007. View Article : Google Scholar : PubMed/NCBI
13	Armstrong AC and Evans GD: Management of women at high risk of breast cancer. BMJ. 348:g27562014. View Article : Google Scholar : PubMed/NCBI
14	Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Cetnarskyj R, Drummond S, Davidson R, Dunlop J, Fordyce A, et al: Predicting breast cancer risk: Implications of a ‘weak' family history. Fam Cancer. 7:361–366. 2008. View Article : Google Scholar
15	Eerola H, Blomqvist C, Pukkala E, Pyrhönen S and Nevanlinna H: Familial breast cancer in southern Finland: How prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer. 36:1143–1148. 2000. View Article : Google Scholar : PubMed/NCBI
16	Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B, Løvslett K, Hovig E and Vabø A: Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers. Eur J Cancer. 43:1713–1717. 2007. View Article : Google Scholar
17	Fackenthal JD and Olopade OI: Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 7:937–948. 2007. View Article : Google Scholar : PubMed/NCBI
18	Harboe TL, Eiberg H, Kern P, Ejlertsen B, Nedergaard L, Timmermans-Wielenga V, Nielsen IM and Bisgaard ML: A high frequent BRCA1 founder mutation identified in the Greenlandic population. Fam Cancer. 8:413–419. 2009. View Article : Google Scholar : PubMed/NCBI
19	Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V and Russo A: Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 18(Suppl 6): vi93–vi98. 2007. View Article : Google Scholar : PubMed/NCBI
20	Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV, Sokolenko AP, Buslov KG, Voskresenskiy DA, Togo AV, Kovalenko SP, Stoep N, et al: Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett. 298:258–263. 2010. View Article : Google Scholar : PubMed/NCBI
21	Sagi M, Eilat A, Ben Avi L, Goldberg Y, Bercovich D, Hamburger T, Peretz T and Lerer I: Two BRCA1/2 founder mutations in Jews of Sephardic origin. Fam Cancer. 10:59–63. 2011. View Article : Google Scholar
22	Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, et al: Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing. J Natl Cancer Inst. 107:3802015. View Article : Google Scholar
23	Corbex M, Bouzbid S and Boffetta P: Features of breast cancer in developing countries, examples from North-Africa. Eur J Cancer. 50:1808–1818. 2014. View Article : Google Scholar : PubMed/NCBI
24	Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ and MacDonald DJ: Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA. 297:2587–2595. 2007. View Article : Google Scholar : PubMed/NCBI
25	Leu M, Czene K and Reilly M: The impact of truncation and missing family links in population-based registers on familial risk estimates. Am J Epidemiol. 166:1461–1467. 2007. View Article : Google Scholar : PubMed/NCBI
26	Leu M, Czene K and Reilly M: Bias correction of estimates of familial risk from population-based cohort studies. Int J Epidemiol. 39:80–88. 2010. View Article : Google Scholar
27	Weitzel JN: Limited Family structure and breast cancer risk. JAMA. 298:Letter. 2007, http://dx.doi.org/10.1001/jama.298.17.2007-b. View Article : Google Scholar
28	Cohen M and Azaiza F: Early breast cancer detection practices, health beliefs, and cancer worries in Jewish and Arab women. Prev Med. 41:852–858. 2005. View Article : Google Scholar : PubMed/NCBI
29	Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q and Phillips RS: Racial and ethnic disparities in cancer screening: The importance of foreign birth as a barrier to care. J Gen Intern Med. 18:1028–1035. 2003. View Article : Google Scholar : PubMed/NCBI
30	Li CI, Malone KE and Daling JR: Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 163:49–56. 2003. View Article : Google Scholar : PubMed/NCBI
31	Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A and Lambe M: Sociodemographic predictors of non-attendance at invitational mammography screening - a population-based register study (Sweden). Cancer Causes Control. 13:73–82. 2002. View Article : Google Scholar : PubMed/NCBI
32	Sassi F, Luft HS and Guadagnoli E: Reducing racial/ethnic disparities in female breast cancer: Screening rates and stage at diagnosis. Am J Public Health. 96:2165–2172. 2006. View Article : Google Scholar : PubMed/NCBI
33	Terán L, Baezconde-Garbanati L, Márquez M, Castellanos E and Belkić K: On-time mammography screening with a focus on Latinas with low income: A proposed cultural model. Anticancer Res. 27(6C): 4325–4338. 2007.
34	Belkić K, Cohen M, Márquez M, Mints M, Wilczek B, Berman AH, Castellanos E and Castellanos M: Screening of high-risk groups for breast and ovarian cancer in Europe: A focus on the Jewish population. Oncol Rev. 4:233–267. 2010. View Article : Google Scholar
35	Sándor J, Havasi V, Kiss I, Szücs M, Brázay L, Sebestyén A and Ember I: Small area inequalities in breast cancer mortality and screening. Magy Onkol. 46:139–145. 2002.(In Hungarian).
36	Copson E, Maishman T, Gerty S, Eccles B, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Jones L, et al; POSH study steering group. Ethnicity and outcome of young breast cancer patients in the United Kingdom: The POSH study. Br J Cancer. 110:230–241. 2014. View Article : Google Scholar :
37	den Heijer M, Seynaeve C, Vanheusden K, Timman R, Duivenvoorden HJ, Tilanus-Linthorst M, Menke-Pluijmers MB and Tibben A: Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: A risk profile. Psychooncology. 22:598–604. 2013. View Article : Google Scholar
38	Essink-Bot ML, Rijnsburger AJ, van Dooren S, de Koning HJ and Seynaeve C: Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition. Breast. 15:673–676. 2006. View Article : Google Scholar : PubMed/NCBI
39	Kriege M, Brekelmans CT, Boetes C, Rutgers EJ, Oosterwijk JC, Tollenaar RA, Manoliu RA, Holland R, de Koning HJ and Klijn JG: MRI screening for breast cancer in women with familial or genetic predisposition: Design of the Dutch National Study (MRISC). Fam Cancer. 1:163–168. 2001. View Article : Google Scholar
40	Kriege M, Brekelmans CTM, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM, et al; Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 351:427–437. 2004. View Article : Google Scholar : PubMed/NCBI
41	Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Rutgers EJ, de Koning HJ, et al; Dutch MRI Screening (MRISC) Study Group. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer. 106:2318–2326. 2006. View Article : Google Scholar : PubMed/NCBI
42	Kriege M, Brekelmans CT, Peterse H, Obdeijn IM, Boetes C, Zonderland HM, Muller SH, Kok T, Manoliu RA, Besnard AP, et al: Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat. 102:357–363. 2007. View Article : Google Scholar
43	Obdeijn IM, Loo CE, Rijnsburger AJ, Wasser MN, Bergers E, Kok T, Klijn JG and Boetes C: Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition. Breast Cancer Res Treat. 119:399–407. 2010. View Article : Google Scholar
44	Pieterse K, van Dooren S, Seynaeve C, Bartels CC, Rijnsburger AJ, de Koning HJ, Klijn JG, van Elderen T, Tibben A and Duivenvoorden HJ: Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psychooncology. 16:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
45	Rijnsburger AJ, Obdeijn I-M, Kaas R, Tilanus-Linthorst MMA, Boetes C, Loo CE, Wasser MN, Bergers E, Kok T, Muller SH, et al: BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: Long-term follow-up of the Dutch MRISC Screening Study. J Clin Oncol. 28:5265–5273. 2010. View Article : Google Scholar : PubMed/NCBI
46	Tilanus-Linthorst MM, Kriege M, Boetes C, Hop WC, Obdeijn IM, Oosterwijk JC, Peterse HL, Zonderland HM, Meijer S, Eggermont AM, et al: Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer. 41:1610–1617. 2005. View Article : Google Scholar : PubMed/NCBI
47	Albada A, Werrett J, Van Dulmen S, Bensing JM, Chapman C, Ausems MG and Metcalfe A: Breast cancer genetic counselling referrals: How comparable are the findings between the UK and the Netherlands? J Community Genet. 2:233–247. 2011. View Article : Google Scholar : PubMed/NCBI
48	Boetes C: Update on screening breast MRI in high-risk women. Obstet Gynecol Clin North Am. 38:149–158. viii–ix. 2011. View Article : Google Scholar : PubMed/NCBI
49	Lammens CR, Bleiker EM, Aaronson NK, Wagner A, Sijmons RH, Ausems MG, Vriends AH, Ruijs MW, van Os TA, Spruijt L, et al: Regular surveillance for Li-Fraumeni Syndrome: Advice, adherence and perceived benefits. Fam Cancer. 9:647–654. 2010. View Article : Google Scholar : PubMed/NCBI
50	Fakkert IE, Jansen L, Meijer K, Kok T, Oosterwijk JC, Mourits MJ and de Bock GH: Breast cancer screening in BRCA1 and BRCA2 mutation carriers after risk reducing salpingo-oophorectomy. Breast Cancer Res Treat. 129:157–164. 2011. View Article : Google Scholar : PubMed/NCBI
51	Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ and Oudkerk M: First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat. 63:53–60. 2000. View Article : Google Scholar : PubMed/NCBI
52	Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, et al; UK MRI Breast Screening Study Advisory Group. Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast. 9:78–82. 2000. View Article : Google Scholar
53	Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Hayes C, Jenkins JP, et al; UK MRI Breast Screening Study Advisory Group. Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast. 9:72–77. 2000. View Article : Google Scholar
54	Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA, Evans DG, Gilbert FG, Graves M, et al; UK MRI Breast Screening Study Advisory Group. Magnetic resonance imaging screening in women at genetic risk of breast cancer: Imaging and analysis protocol for the UK multicentre study. Magn Reson Imaging. 18:765–776. 2000. View Article : Google Scholar : PubMed/NCBI
55	Evans DG, Lennard F, Pointon LJ, Ramus SJ, Gayther SA, Sodha N, Kwan-Lim GE, Leach MO, Warren R, Thompson D, et al; UK Study of MRI Screening for Breast Cancer in Women at High Risk (MARIBS). Eligibility for magnetic resonance imaging screening in the United Kingdom: Effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study. Cancer Epidemiol Biomarkers Prev. 18:2123–2131. 2009. View Article : Google Scholar : PubMed/NCBI
56	Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, et al: Breast cancer risk in young women in the national breast screening programme: Implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res (Phila). 7:993–1001. 2014. View Article : Google Scholar
57	Evans DG, Kesavan N, Lim Y, Gadde S, Hurley E, Massat NJ, Maxwell AJ, Ingham S, Eeles R, Leach MO, et al; MARIBS Group. MRI breast screening in high-risk women: Cancer detection and survival analysis. Breast Cancer Res Treat. 145:663–672. 2014. View Article : Google Scholar : PubMed/NCBI
58	Gilbert FJ, Warren RM, Kwan-Lim G, Thompson DJ, Eeles RA, Evans DG and Leach MO; United Kingdom Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology. 252:358–368. 2009. View Article : Google Scholar : PubMed/NCBI
59	Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, et al; UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer. 95:801–810. 2006. View Article : Google Scholar : PubMed/NCBI
60	Gui GP, Hogben RK, Walsh G, A'Hern R and Eeles R: The incidence of breast cancer from screening women according to predicted family history risk: Does annual clinical examination add to mammography? Eur J Cancer. 37:1668–1673. 2001. View Article : Google Scholar : PubMed/NCBI
61	Gui GP, Kadayaprath G, Darhouse N, Self J, Ward A, A'Hern R and Eeles R: Clinical outcome and service implications of screening women at increased breast cancer risk from a family history. Eur J Surg Oncol. 32:719–724. 2006. View Article : Google Scholar : PubMed/NCBI
62	Hutton J, Walker LG, Gilbert FJ, Evans DG, Eeles R, Kwan-Lim GE, Thompson D, Pointon LJ, Sharp DM and Leach MO; UK Study Group for MRI Screening in Women at High Risk Study. Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: The MARIBS Study. Br J Cancer. 104:578–586. 2011. View Article : Google Scholar : PubMed/NCBI
63	Leach MO, Eeles RA, Turnbull LW, Dixon AK, Brown J, Hoff RJ, Coulthard A, Dixon JM, Easton DF, Evans DG, et al; Magnetic Resonance Imaging as a Method of Screening for Breast Cancer Advisory Group. The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res. 21(Suppl 3): 107–114. 2002.
64	Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG, Gilbert FJ, Griebsch I, Hoff RJ, Kessar P, et al; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet. 365:1769–1778. 2005. View Article : Google Scholar : PubMed/NCBI
65	Thompson DJ, Leach MO, Kwan-Lim G, Gayther SA, Ramus SJ, Warsi I, Lennard F, Khazen M, Bryant E, Reed S, et al; UK study of MRI screening for breast cancer in women at high risk (MARIBS). Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study. Breast Cancer Res. 11:R802009. View Article : Google Scholar : PubMed/NCBI
66	Tilanus-Linthorst MM, Obdeijn IM and Bartels KC: MARIBS study. Lancet. 366:291–292. 2005. View Article : Google Scholar : PubMed/NCBI
67	Warren RM, Thompson D, Pointon LJ, Hoff R, Gilbert FJ, Padhani AR, Easton DF, Lakhani SR and Leach MO; Collaborators in the United Kingdom Medical Research Council Magnetic Resonance Imaging in Breast Screening (MARIBS) Study. Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening study. Radiology. 239:677–685. 2006. View Article : Google Scholar : PubMed/NCBI
68	Gilbert FJ: Breast cancer screening in high risk women. Cancer Imaging. 8(Spec No A): S6–S9. 2008.http://dx.doi.org/10.1102/1470-7330.2008.9002. View Article : Google Scholar : PubMed/NCBI
69	Leach MO: Breast cancer screening in women at high risk using MRI. NMR Biomed. 22:17–27. 2009. View Article : Google Scholar
70	Murday V, Pears R, Ball J, Eeles R and Hodgson S: An audit of screening for familial breast cancer before 50 years in the South Thames Region - have we got it right? Fam Cancer. 3:29–34. 2004. View Article : Google Scholar : PubMed/NCBI
71	Kollias J, Sibbering DM, Blamey RW, Holland PA, Obuszko Z, Wilson AR, Evans AJ, Ellis IO and Elston CW: Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer. 34:878–883. 1998. View Article : Google Scholar : PubMed/NCBI
72	Reis MM, Tavakoli M, Dewar J, Goudie D, Cook A, McLeish L, Young D, Kenyon J and Steel M: Evaluation of a surveillance programme for women with a family history of breast cancer. J Med Genet. 46:319–323. 2009. View Article : Google Scholar : PubMed/NCBI
73	Brain K, Henderson BJ, Tyndel S, Bankhead C, Watson E, Clements A and Austoker J; PIMMS Study Management Group. Predictors of breast cancer-related distress following mammography screening in younger women on a family history breast screening programme. Psychooncology. 17:1180–1188. 2008. View Article : Google Scholar : PubMed/NCBI
74	Tyndel S, Clements A, Bankhead C, Henderson BJ, Brain K, Watson E and Austoker J; PIMMS Study Management Group. Mammographic screening for young women with a family history of breast cancer: Knowledge and views of those at risk. Br J Cancer. 99:1007–1012. 2008. View Article : Google Scholar : PubMed/NCBI
75	Evans DG, Harvie M, Bundred N and Howell A: Uptake of breast cancer prevention and screening trials. J Med Genet. 47:853–855. 2010. View Article : Google Scholar : PubMed/NCBI
76	Howell SJ, Searle C, Goode V, Gardener T, Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, et al: The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage. Br J Cancer. 101:582–588. 2009. View Article : Google Scholar : PubMed/NCBI
77	Evans DG, Thomas S, Caunt J, Roberts L, Howell A, Wilson M, Fox R, Sibbering DM, Moss S, Wallis MG, et al; FH02 study group. Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02). Fam Cancer. 13:13–21. 2014. View Article : Google Scholar
78	Schmutzler RK, Rhiem K, Breuer P, Wardelmann E, Lehnert M, Coburger S and Wappenschmidt B: Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prev. 15:483–489. 2006. View Article : Google Scholar : PubMed/NCBI
79	Kuhl CK: High-risk screening: Multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). J Exp Clin Cancer Res. 21(Suppl 3): 103–106. 2002.
80	Kuhl CK, Schrading S, Leutner CC, Morakkabati-Spitz N, Wardelmann E, Fimmers R, Kuhn W and Schild HH: Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol. 23:8469–8476. 2005. View Article : Google Scholar : PubMed/NCBI
81	Kuhl CK, Kuhn W and Schild H: Management of women at high risk for breast cancer: New imaging beyond mammography. Breast. 14:480–486. 2005. View Article : Google Scholar : PubMed/NCBI
82	Schrading S and Kuhl CK: Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology. 246:58–70. 2008. View Article : Google Scholar
83	Meindl A; German Consortium for Hereditary Breast and Ovarian Cancer. Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer. 97:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
84	Lux MP, Ackermann S, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW and Fasching PA: Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer. Eur J Cancer Prev. 14:399–411. 2005. View Article : Google Scholar : PubMed/NCBI
85	Lux MP, Ackermann S, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R, Bender HG, Beckmann MW and Fasching PA: Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer. Eur J Cancer Prev. 14:503–511. 2005. View Article : Google Scholar : PubMed/NCBI
86	Sardanelli F, Podo F, D'Agnolo G, Verdecchia A, Santaquilani M, Musumeci R, Trecate G, Manoukian S, Morassut S, de Giacomi C, et al; High Breast Cancer Risk Italian Trial. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): Interim results. Radiology. 242:698–715. 2007. View Article : Google Scholar : PubMed/NCBI
87	Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S, et al; High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): Final results. Invest Radiol. 46:94–105. 2011. View Article : Google Scholar
88	Sardanelli F, Giuseppetti GM, Canavese G, Cataliotti L, Corcione S, Cossu E, Federico M, Marotti L, Martincich L, Panizza P, et al: Indications for breast magnetic resonance imaging. Consensus document ‘Attualità in senologia', Florence 2007. Radiol Med (Torino). 113:1085–1095. 2008. View Article : Google Scholar
89	Manfrin E, Mariotto R, Remo A, Reghellin D, Falsirollo F, Dalfior D, Bricolo P, Piazzola E and Bonetti F: Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: Five years' experience of the Breast Cancer Screening Program in Verona (1999–2004). Cancer. 115:499–507. 2009. View Article : Google Scholar : PubMed/NCBI
90	Santoro F, Podo F and Sardanelli F: MRI screening of women with hereditary predisposition to breast cancer: Diagnostic performance and survival analysis. Breast Cancer Res Treat. 147:685–687. 2014. View Article : Google Scholar : PubMed/NCBI
91	Cortesi L, Turchetti D, Marchi I, Fracca A, Canossi B, Rachele B, Silvia R, Rita PA, Pietro T and Massimo F: Breast cancer screening in women at increased risk according to different family histories: An update of the Modena Study Group experience. BMC Cancer. 6:2102006. View Article : Google Scholar : PubMed/NCBI
92	Cortesi L, Pecchi A, De Matteis E, Filieri E, Battista R, Canossi B, Torricelli P and Federico M: MRI in high risk women: Benefits and problems. Eur J Radiol. 81(Suppl 1): S19–S20. 2012. View Article : Google Scholar
93	Federico M, Maiorana A, Mangone L, Turchetti D, Canossi B, Cortesi L, Romagnoli R and Silingardi V: Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: The Modena Study Group proposal. Breast Cancer Res Treat. 55:213–221. 1999. View Article : Google Scholar : PubMed/NCBI
94	Cortesi L, Masini C, Cirilli C, Medici V, Marchi I, Cavazzini G, Pasini G, Turchetti D and Federico M: Favourable ten-year overall survival in a Caucasian population with high probability of hereditary breast cancer. BMC Cancer. 10:902010. View Article : Google Scholar : PubMed/NCBI
95	Trecate G, Vergnaghi D, Manoukian S, Bergonzi S, Scaperrotta G, Marchesini M, Ferranti C, Peissel B, Spatti G, Bohm S, et al: MRI in the early detection of breast cancer in women with high genetic risk. Tumori. 92:517–523. 2006.
96	Gronwald J, Byrski T, Huzarski T, Cybulski C, Stawicka M, Szwiec M, Debniak T, Tulman A, Sun P, Oszurek O, et al: A survey of preventive measures among BRCA1 mutation carriers from Poland. Clin Genet. 71:153–157. 2007. View Article : Google Scholar : PubMed/NCBI
97	Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, et al: A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer. 110:683–686. 2004. View Article : Google Scholar : PubMed/NCBI
98	Brozek I, Cybulska C, Ratajska M, Piatkowska M, Kluska A, Balabas A, Dabrowska M, Nowakowska D, Niwinska A, Pamula-Pilat J, et al: Prevalence of the most frequent BRCA1 mutations in Polish population. J Appl Genet. 52:325–330. 2011. View Article : Google Scholar : PubMed/NCBI
99	Popiela TJ, Kibil W, Herman-Sucharska I and Urbanik A: The use of magnetic resonance mammography in women at increased risk for developing breast cancer. Wideochir Inne Tech Malo Inwazyjne. 8:55–62. 2013.PubMed/NCBI
100	Brédart A, Kop JL, Fall M, Pelissier S, Simondi C, Dolbeault S, Livartowski A and Tardivon A; Magnetic Resonance Imaging study group (STIC IRM 2005). Anxiety and specific distress in women at intermediate and high risk of breast cancer before and after surveillance by magnetic resonance imaging and mammography versus standard mammography. Psychooncology. 21:1185–1194. 2012. View Article : Google Scholar
101	Brédart A, Kop JL, Fall M, Pelissier S, Simondi C, Dolbeault S, Livartowski A and Tardivon A; Magnetic Resonance Imaging study group (STIC IRM 2005). Perception of care and experience of examination in women at risk of breast cancer undergoing intensive surveillance by standard imaging with or without MRI. Patient Educ Couns. 86:405–413. 2012. View Article : Google Scholar
102	Daguet E, Malhaire C, Hardit C, Athanasiou A, El Khoury C, Thibault F, Ollivier L and Tardivon A; Groupe Femmes à Risque de l'Institut Curie. MR breast screening in patients with genetic mutation. J Radiol. 89:783–790. 2008.(In French). View Article : Google Scholar : PubMed/NCBI
103	Dorval M, Noguès C, Berthet P, Chiquette J, Gauthier-Villars M, Lasset C, Picard C, Plante M, Simard J and Julian-Reynier C; INHERIT BRCAs; GENEPSO Cohort. Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec. Eur J Hum Genet. 19:494–499. 2011. View Article : Google Scholar : PubMed/NCBI
104	Eisinger F, Bressac B, Castaigne D, Cottu PH, Lansac J, Lefranc JP, Lesur A, Noguès C, Pierret J, Puy-Pernias S, et al: Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer. 91:219–237. 2004.(In French). PubMed/NCBI
105	Eisinger F: Breast cancer screening for women with a strong familial risk. Bull Cancer. 92:874–884. 2005.(In French). PubMed/NCBI
106	Lapierre-Combes M, Rousset J, Combes E, Chinelatto S, Dupré PF and André V: Retrospective study conducted in northern Finistère about the role of breast MRI in normal breast screening, experience in 51 patients. Gynecol Obstet Fertil. 37:401–409. 2009.(In French). View Article : Google Scholar : PubMed/NCBI
107	Riedl CC, Ponhold L, Flöry D, Weber M, Kroiss R, Wagner T, Fuchsjäger M and Helbich TH: Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res. 13:6144–6152. 2007. View Article : Google Scholar : PubMed/NCBI
108	Kroiss R, Winkler V, Bikas D, Fleischmann E, Mainau C, Frommlet F, Muhr D, Fuerhauser C, Tea M, Bittner B, et al; Austrian Hereditary Breast and Ovarian Cancer Group. Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers. Hum Mutat. 26:583–589. 2005. View Article : Google Scholar : PubMed/NCBI
109	Kroiss R, Winkler V, Kalteis K, Bikas D, Rudas M, Tea M, Fuerhauser C, Muhr D, Cerny H, Glueck S, et al; Austrian Hereditary Breast and Ovarian Cancer Group. Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: Comparison with a control group. J Cancer Res Clin Oncol. 134:1113–1121. 2008. View Article : Google Scholar : PubMed/NCBI
110	Arver B, Borg A and Lindblom A: First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test. 5:1–8. 2001. View Article : Google Scholar : PubMed/NCBI
111	Arver B, Haegermark A, Platten U, Lindblom A and Brandberg Y: Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: A 12-month follow-up. Fam Cancer. 3:109–116. 2004. View Article : Google Scholar : PubMed/NCBI
112	Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H, Sandelin K, Håkansson S, Andersen TI, Borg A, et al: A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res. 57:2474–2477. 1997.PubMed/NCBI
113	Arver B, Isaksson K, Atterhem H, Baan A, Bergkvist L, Brandberg Y, Ehrencrona H, Emanuelsson M, Hellborg H, Henriksson K, et al: Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: A national survey. Ann Surg. 253:1147–1154. 2011. View Article : Google Scholar : PubMed/NCBI
114	Brandt A, Lorenzo Bermejo J, Sundquist J and Hemminki K: Breast cancer risk in women who fulfill high-risk criteria: At what age should surveillance start? Breast Cancer Res Treat. 121:133–141. 2010. View Article : Google Scholar
115	Czene K, Reilly M, Hall P and Hartman M: A constant risk for familial breast cancer? A population-based family study. Breast Cancer Res. 11:R302009. View Article : Google Scholar : PubMed/NCBI
116	Hemminki K, Ji J and Försti A: Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk. Cancer Res. 67:868–870. 2007. View Article : Google Scholar : PubMed/NCBI
117	Hemminki K, Mousavi SM, Sundquist J and Brandt A: Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. Oncologist. 16:146–154. 2011. View Article : Google Scholar : PubMed/NCBI
118	Margolin S, Werelius B, Fornander T and Lindblom A: BRCA1 mutations in a population-based study of breast cancer in Stockholm county. Genet Test. 8:127–132. 2004. View Article : Google Scholar : PubMed/NCBI
119	Von Wachenfeldt A, Brandberg Y, Johansson H and Fornander T: Socioeconomic status and quality of life of women with family history of breast cancer attending an oncogenetic counseling clinic: A comparison with general population. Acta Oncol. 48:86–92. 2009. View Article : Google Scholar
120	Dørum A, Heimdal K, Løvslett K, Kristensen G, Hansen LJ, Sandvei R, Schiefloe A, Hagen B, Himmelmann A, Jerve F, et al: Prospectively detected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand. 78:906–911. 1999. View Article : Google Scholar : PubMed/NCBI
121	Hagen AI, Kvistad KA, Maehle L, Holmen MM, Aase H, Styr B, Vabø A, Apold J, Skaane P and Møller P: Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series. Breast. 16:367–374. 2007. View Article : Google Scholar : PubMed/NCBI
122	Albrektsen G, Heuch I and Thoresen SØ: Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: A register-based study in Norway. BMC Cancer. 10:2262010. View Article : Google Scholar : PubMed/NCBI
123	Foretova L, Petrakova K, Palacova M, Kalabova R, Svoboda M, Navratilova M, Schneiderova M, Bolcak K, Krejci E, Drazan L, et al: Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience. Klin Onkol. 23:388–400. 2010.
124	Foretova L, Machackova E, Navratilova M, Pavlu H, Hruba M, Lukesova M and Valik D: BRCA1 and BRCA2 mutations in women with familial or early-onset breast/ovarian cancer in the Czech Republic. Hum Mutat. 23:397–398. 2004. View Article : Google Scholar : PubMed/NCBI
125	Mateju M, Stribrna J, Zikan M, Kleibl Z, Janatova M, Kormunda S, Novotny J, Soucek P, Petruzelka L and Pohlreich P: Population-based study of BRCA1/2 mutations: Family history based criteria identify minority of mutation carriers. Neoplasma. 57:280–285. 2010. View Article : Google Scholar : PubMed/NCBI
126	Mulsow J, Lee J, Dempsey C, Rothwell J and Geraghty JG: Establishing a family risk assessment clinic for breast cancer. Breast J. 15(Suppl 1): S33–S38. 2009. View Article : Google Scholar : PubMed/NCBI
127	Brandt RT and Lynch HT: BRCA1 and BRCA2: To test or not to test. Breast Cancer Res Treat. 67:187–188. 2001. View Article : Google Scholar : PubMed/NCBI
128	Surbone A: Ethical implications of genetic testing for breast cancer susceptibility. Crit Rev Oncol Hematol. 40:149–157. 2001. View Article : Google Scholar : PubMed/NCBI
129	Márquez M, Belkić K, Nilsson S and Holmberg AR: Genetic testing in patients with hereditary cancer risk: Social, ethical and legal considerations. Instit Investig Jurid. 383:295–340. 2007.
130	Baider L, Peretz T, Hadani PE, Perry S, Avramov R and De-Nour AK: Transmission of response to trauma? Second-generation Holocaust survivors' reaction to cancer. Am J Psychiatry. 157:904–910. 2000. View Article : Google Scholar : PubMed/NCBI
131	Baider L, Goldzweig G, Ever-Hadani P and Peretz T: Psychological distress and coping in breast cancer patients and healthy women whose parents survived the Holocaust. Psychooncology. 15:635–646. 2006. View Article : Google Scholar
132	Baider L, Goldzweig G, Ever-Hadani P and Peretz T: Breast cancer and psychological distress: Mothers' and daughters' traumatic experiences. Support Care Cancer. 16:407–414. 2008. View Article : Google Scholar
133	Keinan-Boker L, Vin-Raviv N, Liphshitz I, Linn S and Barchana M: Cancer incidence in Israeli Jewish survivors of World War II. J Natl Cancer Inst. 101:1489–1500. 2009. View Article : Google Scholar : PubMed/NCBI
134	Brown DR, Fouad MN, Basen-Engquist K and Tortolero-Luna G: Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol. 10(Suppl 8): S13–S21. 2000. View Article : Google Scholar
135	Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W and Wells SA: A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg. 199:644–651. 2004. View Article : Google Scholar : PubMed/NCBI
136	Guevara C, Cook C, Herback N, Pietrobon R, Jacobs DO and Vail TP: Gender, racial, and ethnic disclosure in NIH K-Award funded diabetes and obesity clinical trials. Account Res. 13:311–324. 2006. View Article : Google Scholar
137	Azaiza F, Cohen M, Awad M and Daoud F: Factors associated with low screening for breast cancer in the Palestinian Authority: Relations of availability, environmental barriers, and cancer-related fatalism. Cancer. 116:4646–4655. 2010. View Article : Google Scholar : PubMed/NCBI
138	Bobo JK, Shapiro JA and Brustrom J: Efforts to locate low-income women for a study on mammography rescreening: Implications for public health practice. J Community Health. 31:249–261. 2006. View Article : Google Scholar : PubMed/NCBI
139	Garbers S, Jessop DJ, Foti H, Uribelarrea M and Chiasson MA: Barriers to breast cancer screening for low-income Mexican and Dominican women in New York City. J Urban Health. 80:81–91. 2003.PubMed/NCBI
140	Otero-Sabogal R, Stewart S, Sabogal F, Brown BA and Pérez-Stable EJ: Access and attitudinal factors related to breast and cervical cancer rescreening: Why are Latinas still under-screened? Health Educ Behav. 30:337–359. 2003. View Article : Google Scholar : PubMed/NCBI
141	Otero-Sabogal R, Owens D, Canchola J, Golding JM, Tabnak F and Fox P: Mammography rescreening among women of diverse ethnicities: Patient, provider, and health care system factors. J Health Care Poor Underserved. 15:390–412. 2004. View Article : Google Scholar : PubMed/NCBI
142	Erwin DO, Johnson VA, Trevino M, Duke K, Feliciano L and Jandorf L: A comparison of African American and Latina social networks as indicators for culturally tailoring a breast and cervical cancer education intervention. Cancer. 109(Suppl 2): 368–377. 2007. View Article : Google Scholar
143	Glanz K, Croyle RT, Chollette VY and Pinn VW: Cancer-related health disparities in women. Am J Public Health. 93:292–298. 2003. View Article : Google Scholar : PubMed/NCBI
144	Meiser B, Eisenbruch M, Barlow-Stewart K, Tucker K, Steel Z and Goldstein D: Cultural aspects of cancer genetics: Setting a research agenda. J Med Genet. 38:425–429. 2001. View Article : Google Scholar : PubMed/NCBI
145	Remennick L: The challenge of early breast cancer detection among immigrant and minority women in multicultural societies. Breast J. 12(Suppl 1): S103–S110. 2006. View Article : Google Scholar : PubMed/NCBI
146	Valdez A, Banerjee K, Ackerson L and Fernandez M: A multi-media breast cancer education intervention for low-income Latinas. J Community Health. 27:33–51. 2002. View Article : Google Scholar : PubMed/NCBI
147	Borrayo EA: Where's Maria? A video to increase awareness about breast cancer and mammography screening among low-literacy Latinas. Prev Med. 39:99–110. 2004. View Article : Google Scholar : PubMed/NCBI
148	Cohen M and Azaiza F: Increasing breast examinations among arab women using a tailored culture-based intervention. Behav Med. 36:92–99. 2010. View Article : Google Scholar : PubMed/NCBI
149	Jibaja-Weiss ML, Volk RJ, Kingery P, Smith QW and Holcomb JD: Tailored messages for breast and cervical cancer screening of low-income and minority women using medical records data. Patient Educ Couns. 50:123–132. 2003. View Article : Google Scholar : PubMed/NCBI
150	Navarro AM, Senn KL, McNicholas LJ, Kaplan RM, Roppé B and Campo MC: Por La Vida model intervention enhances use of cancer screening tests among Latinas. Am J Prev Med. 15:32–41. 1998. View Article : Google Scholar : PubMed/NCBI
151	Remennick L: ‘I have no time for potential troubles': Russian immigrant women and breast cancer screening in Israel. J Immigr Health. 5:153–163. 2003. View Article : Google Scholar : PubMed/NCBI
152	Berg WA, Blume JD, Adams AM, Jong RA, Barr RG, Lehrer DE, Pisano ED, Evans WP III, Mahoney MC, Hovanessian Larsen L, et al: Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 254:79–87. 2010. View Article : Google Scholar :
153	Yu J, Park A, Morris E, Liberman L, Borgen PI and King TA: MRI screening in a clinic population with a family history of breast cancer. Ann Surg Oncol. 15:452–461. 2008. View Article : Google Scholar
154	Robson M: Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations. Clin Breast Cancer. 5:260–268; discussion 269–271. 2004. View Article : Google Scholar : PubMed/NCBI
155	Begley JK, Redpath TW, Bolan PJ and Gilbert FJ: In vivo proton magnetic resonance spectroscopy of breast cancer: A review of the literature. Breast Cancer Res. 14:2072012. View Article : Google Scholar : PubMed/NCBI
156	Belkić K and Belkić D: Possibilities for improved early breast cancer detection by Padé-optimized magnetic resonance spectroscopy. Isr Med Assoc J. 13:236–243. 2011.
157	Katz-Brull R, Lavin PT and Lenkinski RE: Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst. 94:1197–1203. 2002. View Article : Google Scholar : PubMed/NCBI
158	Sardanelli F, Fausto A and Podo F: MR spectroscopy of the breast. Radiol Med (Torino). 113:56–64. 2008. View Article : Google Scholar
159	Tse GM, Yeung DK, King AD, Cheung HS and Yang WT: In vivo proton magnetic resonance spectroscopy of breast lesions: An update. Breast Cancer Res Treat. 104:249–255. 2007. View Article : Google Scholar
160	O'Flynn EA, Wilson RM, Allen SD, Locke I, Scurr E and deSouza NM: Diffusion-weighted imaging of the high-risk breast: Apparent diffusion coefficient values and their relationship to breast density. J Magn Reson Imaging. 39:805–811. 2014. View Article : Google Scholar
161	Eyal E, Shapiro-Feinberg M, Furman-Haran E, Grobgeld D, Golan T, Itzchak Y, Catane R, Papa M and Degani H: Parametric diffusion tensor imaging of the breast. Invest Radiol. 47:284–291. 2012. View Article : Google Scholar : PubMed/NCBI
162	Allgood PC, Warwick J, Warren RML, Day NE and Duffy SW: A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer. 98:206–209. 2008. View Article : Google Scholar
163	Anttila A, Koskela J and Hakama M: Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 9:153–158. 2002. View Article : Google Scholar
164	Duffy SW, Tabár L, Chen HH, Holmqvist M, Yen MF, Abdsalah S, Epstein B, Frodis E, Ljungberg E, Hedborg-Melander C, et al: The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer. 95:458–469. 2002. View Article : Google Scholar : PubMed/NCBI
165	Gabe R, Tryggvadóttir L, Sigfússon BF, Olafsdóttir GH, Sigurđsson K and Duffy SW: A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol. 48:948–955. 2007. View Article : Google Scholar : PubMed/NCBI
166	Morimoto T, Nagao T, Okazaki K, Kira M, Nakagawa Y and Tangoku A: Current status of breast cancer screening in the world. Breast Cancer. 16:2–9. 2009. View Article : Google Scholar
167	Sarkeala T, Anttila A, Saarenmaa I and Hakama M: Validity of process indicators of screening for breast cancer to predict mortality reduction. J Med Screen. 12:33–37. 2005. View Article : Google Scholar : PubMed/NCBI
168	Vahabi M: Breast cancer and screening information needs and preferred communication medium among Iranian immigrant women in Toronto. Health Soc Care Community. 19:626–635. 2011. View Article : Google Scholar : PubMed/NCBI
169	www.unlabs.se/mammografi.
170	Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, Martínez J, Macià F, Quintana MJ, Albanell J and Castells X: Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain. Cancer Causes Control. 21:1155–1164. 2010. View Article : Google Scholar : PubMed/NCBI
171	Vanags A, Štrumfa I, Gardovskis A, Borošenko V, Aboliš A, Teibe U, Trofimovičs G, Miklaševičs E and Gardovskis J: Population screening for hereditary and familial cancer syndromes in Valka district of Latvia. Hered Cancer Clin Pract. 8:82010. View Article : Google Scholar : PubMed/NCBI
172	Venturini E, Losio C, Panizza P, Rodighiero MG, Fedele I, Tacchini S, Schiani E, Ravelli S, Cristel G, Panzeri MM, et al: Tailored breast cancer screening program with microdose mammography, US, and MR Imaging: Short-term results of a pilot study in 40–49-year-old women. Radiology. 268:347–355. 2013. View Article : Google Scholar : PubMed/NCBI
173	Obralić N and Bešlija S: How to make the best use of limited resources in breast cancer treatment - experiences in Bosnia & Herzegovina. J BUON. 11:21–29. 2006.
174	Council of the European Union. Council conclusions on reducing the burden of cancer. In: Employment, Social Policy, Health and Consumer Affairs Council Meeting; Luxembourg. June 10, 2008;